BeStock  
Stocks › Biotechnology › CLYM

Climb Bio CLYM

US equityMarket cap rank #3605Biotechnology
$10.71 +$0.03 (+0.28%)
Market closed · Oct 8, 7:20 am ET · Last extended-hours $10.71 0.00%
Open$10.43
Prev close$10.68
Day range$10.34 – $10.95
Volume755.8K
Market cap$615.14M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-13.1x
CheapRich

Below its usual level · 24th percentile, 5-year average -10.3x

Price / book2.6x
CheapRich

Near the top of its 5-year range · 86th percentile, 5-year average 1.2x

#3423 of 5317 stocks by PB (1 = cheapest)

P/E over five years

-130x-79x-28x23xOct '21Mar '24Oct '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$6.61
Price vs. fair value+62.0%Trading above the estimate
Star rating★★★☆☆
Economic moatNone
UncertaintyExtreme
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.57 – 1.18 86% (pricier than usual) #3423 of 5317 (1 = cheapest)
PE -13.06 -8.63 -10.30 24% (cheaper than usual) –
PS – – 0.00 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Morningstar view

Star rating★★★
Fair value estimate$6.61
Economic moatNone
UncertaintyExtreme

Discussion

No comments yet — be the first to weigh in on CLYM.

Leave a comment

Scroll to Top